Content about Growth factors

October 31, 2012

Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.

January 19, 2012

Drug maker Sandoz has started two late-stage clinical trials of biosimilar drugs for treating cancer patients undergoing chemotherapy, the company said Thursday, saying the studies were meant to support the drugs' eventual marketing in the United States.

January 10, 2012

Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

July 19, 2011

Generic drug maker Teva recently admitted that one of its drugs infringes two of Amgen's patents.

September 29, 2010

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...

September 23, 2010

Several lots of two drugs used to treat anemia are being recalled due to possible...

August 8, 2010

Generic drug maker Dr. Reddy’s has launched in India the world’s first follow-on version of...

August 4, 2010

Biotech company Amgen had $3.8 billion in sales and $1.33 billion in profits during second...

August 2, 2010

Hospira had net sales of $968 million and profits of $83.5 million in second quarter...

January 6, 2010

The Food and Drug Administration plans to review three drugs designed to treat anemia, according...

© 2013 Drug Store News. All Rights Reserved.